Ubicom Holdings. Inc. · TSE:3937
Ubicom — FY2024 Earnings Presentation
30 slides from Ubicom's earnings presentation, May 8, 2025
Slide 1: FY2024 Full Year Financial Results
Ubicom Holdings, Inc. (Prime Market of TSE: 3937) FY2024 ended March 31, 2025 Full Year Financial Results May. 8, 2025
Slide 2: Table of Contents
Table of Contents 01 Overview of consolidated financial results (P/L) for FY2024 P.3 02 Medical Business P.8 03 Technology Consulting Business P.17 04 Business Forecast P.21 05 Dividend Policy P.23 06 Appendix P.25 © Ubicom Holdings, Inc. 2
Slide 3: Overview of Consolidated Financial Results (P/L) for FY2024
Overview of Consolidated Financial Results (P/L) for FY2024 Sales, operating income, ordinary income, and net income all reached record highs for the full fiscal year. Consolidated sales increased by 106.7% YoY to 6,340 million yen. Operating income rose by 122.7% YoY to 1,315 million yen. Net incom
Slide 4: Trends in Consolidated Result for FY 2024
Trends in Consolidated Result for FY 2024 Operating Ordinary Net income Sales income income (Unit : million yen) Operating Margin (Unit : million yen) (Unit : million yen) ＋ 2.7％ (Unit : million yen) 1,400 20.7% 1600 900 6,000 YoY 6,340 1400 800 1,200 1,315 858 5,000 5,942 18.0% 700 1200 1,000 1,341
Slide 5: Segment Overview for FY 2024
Segment Overview for FY 2024 Both business segments recorded increases in revenue and profit, reaching all-time highs. Full-Year of FY2023 Full-Year of FY2024 (Accumulated) (Accumulated) YoY (Unit：million yen) Variance Comparison Amount Sales Ratio Amount Sales Ratio MD 1,646 100.0% 1,723 100.0% 104
Slide 6: FY2024 Full-Year Segment Overview (Performance and Ratios)
FY2024 Full-Year Segment Overview (Performance and Ratios) ➀ Medical Business ～Provision of management supporting solutions for medical institutions～ Business segments ② Technology Consulting Business ～Lab-based partnership and offshore transfer consulting～ The technology consulting business The med
Slide 7: Our Business Model: A Model for Resolving Social Issues in Japan
Our Business Model: A Model for Resolving Social Issues in Japan, A Developed Country Facing Challenges 01 Medical Business 02 Technology Consulting Business Reforming the workstyle of Addressing the shortage medical professionals of 787,000* IT engineers Improving the profitability Mission by 2030
Slide 8: Medical Business
Medical Business 8
Slide 9: Medical Business: FY2024 Full-Year Segment Performance Overview
Medical Business： FY2024 Full-Year Segment Performance Overview By implementing the following measures, the company achieved record highs in both sales and operating income through the stock expansion of the Mighty series using the AI × subscription model and increased average user unit price. The o
Slide 10: Medical Business Performance Trends
Medical Business Performance Trends Achieved record-high results through the expansion of a high-profit foundation built on the subscription model. （Unit：million yen) 1,723 Sales 1,646 Operating income 1,520 65.5% 1,484 Operating margin 1,435 61.4% 1,282 1,301 58.9% 57.0% 1,169 51.1% 1,076 45.4% 1,1
Slide 11: User's Trend of the Core Solution Mighty Series
AI×Subscription Model User’s Trend of the Core Solution「Mighty」Series The implementation of workstyle reforms for medical doctors in April 2024 has led to an acceleration of digital transformation in the medical industry. While focusing on converting existing users, the number of users is steadily i
Slide 12: Medical Business Revenue Growth Strategy for FY 2025
Medical Business Revenue Growth Strategy for FY 2025 Expanding Medical Business Revenue with Two Strategies Product replacement Acquire new users for existing users Increase in unit price due to replacement with new products. M&A strategies License fees will continue to accumulate steadily beyond th
Slide 13: Strategic Partnerships Anticipating M&A with Distributors (1)
Built a growth model through strategic partnerships anticipating M&A with distributors ① Deepened collaboration with ISM strengthening business expansion in the Kyushu area with an eye toward future M&A. 01 02Replacement to new products 03 Sales know-how x Regional network Expand direct sales channe
Slide 14: Three Expected Benefits of M&A with ISM
Built a growth model through strategic partnerships anticipating M&A with distributors ② Three Expected Benefits of M&A with ISM Visions of Future Transition through M&A Strategy 03 Developing new hospital clients 02 Improving profitability through product replacement Current revenues 01 Distributor
Slide 15: Strong Local Sales Network with Numerous Agent Relationships
Built a growth model through strategic partnerships anticipating M&A with distributors ③ Strong local sales network with numerous agent relationships already in place. 95% of Mighty series sales are made via sales agents Positioned the strategic partnership with ISM as a 95% success model and will c
Slide 16: Scenario for Medium- to Long-Term Growth in the Medical Business
Scenario for Medium- to Long-Term Growth in the Medical Business In addition to expanding new platform businesses by leveraging the customer base, medical database, and intellectual property, we are promoting the enhancement of our revenue base and the development of new recurring models through M&A
Slide 17: Technology Consulting Business
Technology Consulting Business 17
Slide 18: Technology Consulting Business: FY2024 Full-Year Segment Performance Overview
Technology Consulting Business： FY2024 Full-Year Segment Performance Overview The delay in SIer-related projects that occurred in FY2023 3Q was resolved through the strengthening of the consulting business and organizational reforms, resulting in record highs in both sales and operating income. The
Slide 19: Investments to Reinforce Mid- to Long-Term Profitability from FY2025
Beginning in FY2025, investments will be initiated the aim of reinforcing its mid-to long-term profitability. External Environment U.S. tariffs have increased price pressure from some Changes in Supply Chain originating from U.S.-China relations clients, mainly in manufacturing China's domestic econ
Slide 20: Technology Consulting Business FY2025 Policy
Technology Consulting Business FY2025 Policy With a view to further growth in FY2025 3Q and beyond, measures to strengthen profitability over 8,000 the medium to long term, while anticipating short-term cost increases, will be implemented. 7,000 6,000 01 Continue strategic order selection with a foc
Slide 21: Business Forecast
Business Forecast 21
Slide 22: Business Forecast and Performance Trends
Business Forecast and Performance Trends （Unit：million yen） Full-scale start of the second growth phase 3,5 00 12,400 営業利益 Operating income 3,0 00 Operating income from New Businesses, Alliances, and M&A 10,400 今後の新規事業・業務提携・M&Aによる営業利益 2,5 00 Sales 売上高 April, 2022 8,4 00 Moved to TSE Prime Market Dec
Slide 23: Dividend Policy
Dividend Policy 23
Slide 24: Dividend Policies to Enable Shareholders to Share in the Benefits of Growth
Dividend Policies to Enable Shareholders to Share in the Benefits from the Growth of Our Company 【Dividend Policies】 ➀ We aim to distribute profits to shareholders stably. ② To increase the dividend amount about three times from the previous fiscal year, while maintaining a good balance between the
Slide 25: Appendix
Appendix 25
Slide 26: Promotion of Our Group's Business That is Socially Meaningful
Promotion of Our Group’s Business That is Socially Meaningful Considering business and capital alliances with leading global companies for the second growth phase Provision of solutions that are beneficial to three key areas: pressing need for workstyles Growing demand due to the reforms for medical
Slide 27: ESG: For Sustainable Growth of Business, Society, and Client Companies
ESG：For sustainable growth of business, society, and client companies Goals Concrete Activities Related SDGs ・To make the electric power consumed at E ・To reduce CO2 emissions the head office 100% derived from renewable energy ・Global partnership ・Investment in equipment of subsidiaries in the Phili
Slide 28: Corporate Profile
Corporate Profile ■Corporate name: Ubicom Holdings, Inc. (Prime Market of TSE: 3937) ■Strategic markets: healthcare, finance, public services, automobiles, manufacturing, robotics, etc. ■Business description: Technology Consulting Business In order to solve the problem of shortage of IT engineers an
Slide 29: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements The materials and information provided in this announcement include forward-looking statements based on our current estimates and expectations at this point of time. Such forward-looking statements are subject to various risks and uncertaintie
Slide 30: Holdings, Inc.
Holdings, Inc. = fe) Q Q =) 30